Costs of implementing a behavioral weight-loss and lifestyle-change program for individuals with serious mental illnesses in community settings

Translational Behavioral Medicine
Scott P StumboCarla A Green

Abstract

Little research has examined costs of adopting a successful lifestyle intervention for people with serious mental illnesses in community clinics. The study aims to calculate the real-world costs of implementing a group-based weight-loss and lifestyle intervention in community settings. We used empirically derived costs to estimate implementation costs and conducted sensitivity analyses to estimate costs: (1) when implementing the intervention in high/low resource-intensive environments and (2) assuming variability in participant enrollment. To implement the STRIDE program for 15 individuals with serious mental illnesses, we estimated costs for the 12-month (30-session) intervention, with materials available in the public domain, at $16,427 or $1095 per participant. The majority of costs, $12,767, were associated with direct labor costs. Replication costs are largely associated with labor. Community health centers offer an untapped resource for implementing behavioral-lifestyle interventions, particularly under the Affordable Care Act, though additional payment reforms or incentives may be needed.

References

Jan 1, 1996·Comprehensive Psychiatry·S MukherjeeP L Scapicchio
May 22, 1998·Medical Care·R T MeenanT M Vogt
Dec 8, 1998·The American Journal of Psychiatry·B G Druss, R A Rosenheck
Apr 24, 2003·JAMA : the Journal of the American Medical Association·Lawrence J AppelUNKNOWN Writing Group of the PREMIER Collaborative Research Group
Jan 30, 2004·Diabetes Care·Jamy D ArdUNKNOWN PREMIER study
Jan 7, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tony CohnGary Remington
Feb 14, 2006·Schizophrenia Bulletin·Faith B DickersonLisa B Dixon
Apr 28, 2006·Acta Psychiatrica Scandinavica·F B DickersonL B Dixon
May 29, 2008·Administration and Policy in Mental Health·Amy M KilbourneFrederic C Blow
Aug 6, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Benjamin G DrussBarbara Mauer
Mar 17, 2009·American Journal of Preventive Medicine·David B AllisonJonathan E Alpert
Mar 18, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Debra P RitzwollerRussell E Glasgow
Dec 1, 2009·American Journal of Preventive Medicine·M Kaye KramerTrevor J Orchard
Apr 23, 2010·Journal of Clinical Pharmacology·Parminder S ChaggarSimon G Williams
May 5, 2010·Health Affairs·Vidhya AlakesonRuth E Katz
Apr 13, 2011·The International Journal of Behavioral Nutrition and Physical Activity·Nick VerhaegheLieven Annemans
Oct 25, 2011·Psychiatric Rehabilitation Journal·Sarah Stark CasagrandeGail L Daumit
Sep 13, 2012·The International Journal of Behavioral Nutrition and Physical Activity·Marieke F van WierMaurits W van Tulder
Mar 27, 2013·American Journal of Preventive Medicine·Michael S LawlorDavid C Goff
Mar 23, 2013·The New England Journal of Medicine·Gail L DaumitLawrence J Appel
Aug 2, 2013·The New England Journal of Medicine·Gail L DaumitLawrence J Appel
Aug 2, 2013·The New England Journal of Medicine·Joshua R Ackerman
Feb 11, 2014·The Primary Care Companion to CNS Disorders·J Ryan ShackelfordMartha Shumway
Mar 22, 2014·Translational Behavioral Medicine·Susan T Azrin, David A Chambers
Sep 16, 2014·The American Journal of Psychiatry·Carla A GreenVictor J Stevens
Jul 28, 2015·Psychiatric Rehabilitation Journal·Bobbi Jo H YarboroughCarla A Green

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.